JP4584715B2 - 持続放出性医薬組成物 - Google Patents

持続放出性医薬組成物 Download PDF

Info

Publication number
JP4584715B2
JP4584715B2 JP2004545913A JP2004545913A JP4584715B2 JP 4584715 B2 JP4584715 B2 JP 4584715B2 JP 2004545913 A JP2004545913 A JP 2004545913A JP 2004545913 A JP2004545913 A JP 2004545913A JP 4584715 B2 JP4584715 B2 JP 4584715B2
Authority
JP
Japan
Prior art keywords
cefquinome
composition
sustained release
oil
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004545913A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006510607A5 (enExample
JP2006510607A (ja
Inventor
シユミツト，ペーター
ボツテナー，アレクサンダー
シユミツト，カルステン
アラン，マルク
バルボ，カロル
Original Assignee
インターベツト・インターナシヨナル・ベー・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベツト・インターナシヨナル・ベー・ベー filed Critical インターベツト・インターナシヨナル・ベー・ベー
Publication of JP2006510607A publication Critical patent/JP2006510607A/ja
Publication of JP2006510607A5 publication Critical patent/JP2006510607A5/ja
Application granted granted Critical
Publication of JP4584715B2 publication Critical patent/JP4584715B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2004545913A 2002-10-25 2003-10-20 持続放出性医薬組成物 Expired - Lifetime JP4584715B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079477 2002-10-25
PCT/EP2003/011644 WO2004037265A1 (en) 2002-10-25 2003-10-20 Prolonged release pharmaceutical composition

Publications (3)

Publication Number Publication Date
JP2006510607A JP2006510607A (ja) 2006-03-30
JP2006510607A5 JP2006510607A5 (enExample) 2006-11-30
JP4584715B2 true JP4584715B2 (ja) 2010-11-24

Family

ID=32116298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004545913A Expired - Lifetime JP4584715B2 (ja) 2002-10-25 2003-10-20 持続放出性医薬組成物

Country Status (18)

Country Link
EP (1) EP1558263B1 (enExample)
JP (1) JP4584715B2 (enExample)
CN (1) CN1326526C (enExample)
AR (1) AR041713A1 (enExample)
AT (1) ATE327759T1 (enExample)
AU (1) AU2003279302B2 (enExample)
BR (2) BRPI0315513B1 (enExample)
CA (1) CA2501395C (enExample)
CO (1) CO5700769A2 (enExample)
DE (1) DE60305728T2 (enExample)
ES (1) ES2265590T3 (enExample)
MX (1) MXPA05004219A (enExample)
NO (1) NO334158B1 (enExample)
NZ (1) NZ539478A (enExample)
PL (1) PL208585B1 (enExample)
PT (1) PT1558263E (enExample)
WO (1) WO2004037265A1 (enExample)
ZA (1) ZA200502956B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
BRPI0911048A2 (pt) 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法
CN117982413B (zh) * 2024-04-03 2024-06-18 山东恒邦中科生物工程有限公司 一种硫酸头孢喹肟注射液的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
GB9907916D0 (en) * 1999-04-07 1999-06-02 Takeda Chemical Industries Ltd Long-acting antibacterial composition
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Also Published As

Publication number Publication date
CA2501395A1 (en) 2004-05-06
CN1326526C (zh) 2007-07-18
DE60305728D1 (de) 2006-07-06
MXPA05004219A (es) 2005-06-08
NO334158B1 (no) 2013-12-23
BR0315513A (pt) 2005-08-23
ZA200502956B (en) 2006-03-29
ATE327759T1 (de) 2006-06-15
NO20051654L (no) 2005-05-24
AR041713A1 (es) 2005-05-26
ES2265590T3 (es) 2007-02-16
JP2006510607A (ja) 2006-03-30
AU2003279302B2 (en) 2008-10-16
EP1558263A1 (en) 2005-08-03
CN1705483A (zh) 2005-12-07
DE60305728T2 (de) 2006-10-12
NZ539478A (en) 2006-05-26
EP1558263B1 (en) 2006-05-31
PL208585B1 (pl) 2011-05-31
CO5700769A2 (es) 2006-11-30
BRPI0315513B1 (pt) 2017-11-28
CA2501395C (en) 2011-05-24
PT1558263E (pt) 2006-10-31
WO2004037265A1 (en) 2004-05-06
AU2003279302A1 (en) 2004-05-13
PL376840A1 (pl) 2006-01-09

Similar Documents

Publication Publication Date Title
JP4584715B2 (ja) 持続放出性医薬組成物
CA2502025C (en) Pharmaceutical compositions having a modified vehicle
JP6781717B2 (ja) 駆虫薬の大環状ラクトンを含むミクロスフェア
US6911441B2 (en) Prolonged release pharmaceutical composition
BRPI0913297B1 (pt) composição farmacêutica estabilizada
AU2001288323B2 (en) Pharmaceutical composition having modified carrier
AU2001288323A1 (en) Pharmaceutical composition having modified carrier
JP2002161033A (ja) 非経口投与用の安定な組成物及びそれらの使用
US20020068065A1 (en) Pharmaceutical composition having specific water activity
KR102798067B1 (ko) 아목시실린을 포함하는 반려동물용 지속형 항생제 및 이의 용도
RU2563826C1 (ru) Инъекционная антибактериальная фармацевтическая композиция
JP7323630B2 (ja) 使用準備が整った注射用製剤
RU2777360C1 (ru) Готовые к применению лекарственные формы для инъекций
Papich et al. The compliance story: what it is, does, and how to achieve it.
HK1156876B (en) Composition comprising an antibiotic and a corticosteroid

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061006

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100628

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100817

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100902

R150 Certificate of patent or registration of utility model

Ref document number: 4584715

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130910

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term